vs
Side-by-side financial comparison of Claros Mortgage Trust, Inc. (CMTG) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $46.7M, roughly 1.6× Claros Mortgage Trust, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -22.4%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -10.9%).
Claros Mortgage Trust, Inc. is a U.S.-based real estate investment trust that invests in diversified mortgage-related assets, including residential and commercial mortgage loans and mortgage-backed securities. It pursues stable, risk-adjusted long-term returns for shareholders via rigorous asset evaluation and active portfolio management.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
CMTG vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $46.7M | $75.5M |
| Net Profit | $-219.2M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | — | 22.7% |
| Net Margin | -468.9% | — |
| Revenue YoY | -22.4% | 27.7% |
| Net Profit YoY | -117.7% | — |
| EPS (diluted) | $-1.56 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $46.7M | $75.5M | ||
| Q3 25 | $46.1M | $54.5M | ||
| Q2 25 | $51.6M | $52.4M | ||
| Q1 25 | $43.4M | $46.0M | ||
| Q4 24 | $60.2M | $59.1M | ||
| Q3 24 | $64.9M | $80.5M | ||
| Q2 24 | $64.5M | $47.1M | ||
| Q1 24 | $58.8M | $43.8M |
| Q4 25 | $-219.2M | — | ||
| Q3 25 | $-9.5M | $8.8M | ||
| Q2 25 | $-181.7M | $5.9M | ||
| Q1 25 | $-78.6M | $3.0M | ||
| Q4 24 | $-100.7M | — | ||
| Q3 24 | $-56.2M | $20.3M | ||
| Q2 24 | $-11.6M | $-4.5M | ||
| Q1 24 | $-52.8M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | — | 22.7% | ||
| Q3 25 | — | 17.6% | ||
| Q2 25 | — | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | — | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | — | -4.6% | ||
| Q1 24 | — | -5.3% |
| Q4 25 | -468.9% | — | ||
| Q3 25 | -20.7% | 16.2% | ||
| Q2 25 | -351.9% | 11.2% | ||
| Q1 25 | -181.3% | 6.5% | ||
| Q4 24 | -167.2% | — | ||
| Q3 24 | -86.7% | 25.2% | ||
| Q2 24 | -17.9% | -9.6% | ||
| Q1 24 | -89.7% | -11.0% |
| Q4 25 | $-1.56 | $0.26 | ||
| Q3 25 | $-0.07 | $0.17 | ||
| Q2 25 | $-1.30 | $0.12 | ||
| Q1 25 | $-0.56 | $0.06 | ||
| Q4 24 | $-0.72 | $0.40 | ||
| Q3 24 | $-0.40 | $0.41 | ||
| Q2 24 | $-0.09 | $-0.09 | ||
| Q1 24 | $-0.39 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $173.2M | $97.5M |
| Total DebtLower is stronger | $3.2B | $22.7M |
| Stockholders' EquityBook value | $1.5B | $130.3M |
| Total Assets | $4.7B | $216.3M |
| Debt / EquityLower = less leverage | 2.06× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $173.2M | $97.5M | ||
| Q3 25 | $339.5M | $94.4M | ||
| Q2 25 | $209.2M | $96.0M | ||
| Q1 25 | $127.8M | $93.2M | ||
| Q4 24 | $99.1M | $101.0M | ||
| Q3 24 | $113.9M | $96.7M | ||
| Q2 24 | $148.2M | $96.8M | ||
| Q1 24 | $232.5M | $107.2M |
| Q4 25 | $3.2B | $22.7M | ||
| Q3 25 | $3.7B | $34.0M | ||
| Q2 25 | $4.0B | $45.3M | ||
| Q1 25 | $4.7B | $56.7M | ||
| Q4 24 | $4.9B | $68.0M | ||
| Q3 24 | $5.1B | $79.3M | ||
| Q2 24 | $5.3B | $90.7M | ||
| Q1 24 | $5.5B | $102.0M |
| Q4 25 | $1.5B | $130.3M | ||
| Q3 25 | $1.7B | $115.3M | ||
| Q2 25 | $1.8B | $104.7M | ||
| Q1 25 | $1.9B | $97.1M | ||
| Q4 24 | $2.0B | $92.1M | ||
| Q3 24 | $2.1B | $71.1M | ||
| Q2 24 | $2.2B | $48.5M | ||
| Q1 24 | $2.2B | $51.0M |
| Q4 25 | $4.7B | $216.3M | ||
| Q3 25 | $5.4B | $202.9M | ||
| Q2 25 | $5.8B | $194.9M | ||
| Q1 25 | $6.7B | $196.2M | ||
| Q4 24 | $7.0B | $213.3M | ||
| Q3 24 | $7.3B | $220.7M | ||
| Q2 24 | $7.6B | $205.0M | ||
| Q1 24 | $7.8B | $214.1M |
| Q4 25 | 2.06× | 0.17× | ||
| Q3 25 | 2.09× | 0.30× | ||
| Q2 25 | 2.29× | 0.43× | ||
| Q1 25 | 2.42× | 0.58× | ||
| Q4 24 | 2.44× | 0.74× | ||
| Q3 24 | 2.44× | 1.12× | ||
| Q2 24 | 2.46× | 1.87× | ||
| Q1 24 | 2.47× | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-30.5M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-30.5M | $14.4M | ||
| Q3 25 | $8.8M | $9.7M | ||
| Q2 25 | $-5.8M | $14.1M | ||
| Q1 25 | $-35.8M | $3.6M | ||
| Q4 24 | $84.5M | $15.6M | ||
| Q3 24 | $39.2M | $11.0M | ||
| Q2 24 | $5.5M | $1.0M | ||
| Q1 24 | $21.5M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CMTG
| Real Estate Owned Portfolio | $34.2M | 73% |
| Other | $11.1M | 24% |
| Mixed Use Property Fixed Rents | $1.4M | 3% |
PBYI
Segment breakdown not available.
